Amgen Announces Tezepelumab Biologics License Application Submitted To U.S. FDA
Go back to Amgen Announces Tezepelumab Biologics License Application Submitted To U.S. FDA| Amgen Inc (NASDAQ: AMGN) | Delayed: 425.28 +5.90 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $419.38 | 52 Week High | $176.85 | |||
| Open | $421.64 | 52 Week Low | $133.64 | |||
| Day High | $427.39 | P/E | 64.05 | |||
| Day Low | $420.72 | EPS | $6.64 | |||
| Volume | 2,591,597 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 3,001,522 | |||||
